Augment Health, Inc. has filed a new offering under Rule 506(b) of the Securities Act, seeking to raise $1 million. As of the filing date, the company has already sold $320,000 of this offering. This move is significant as it reflects Augment Health's ongoing efforts to secure funding for its operations and growth.
The filing, dated October 21, 2026, is part of the company's strategy to enhance its financial position within the competitive manufacturing industry. By utilizing this private offering, Augment Health aims to attract investors and bolster its resources.
Background
Augment Health, Inc. is a corporation incorporated in Delaware, with its business address located at 2100 West End Ave., Office Tower 13th Floor, Nashville, TN. The company is classified under the manufacturing industry group. The recent filing is part of a series of offerings, with the most recent prior filing occurring on November 13, 2025.
What the Filing Says
The filing indicates that the total offering amount is set at $1 million, with $320,000 already sold and $680,000 remaining. The document states, "Rule 506(b) provides a 'safer harbor' for a private offering." This suggests that Augment Health is leveraging regulatory provisions to facilitate its fundraising efforts.
Impact
This offering may affect a variety of stakeholders, including potential investors looking for opportunities in the manufacturing sector. It also signals to competitors that Augment Health is actively seeking to expand its financial base, which could lead to increased competition within the industry.
What's Next
The filing does not say what happens next.